These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38514769)

  • 1. Long-term risk of psychiatric disorder and psychotropic prescription after SARS-CoV-2 infection among UK general population.
    Wang Y; Su B; Xie J; Garcia-Rizo C; Prieto-Alhambra D
    Nat Hum Behav; 2024 Jun; 8(6):1076-1087. PubMed ID: 38514769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of mental health outcomes in people with covid-19: cohort study.
    Xie Y; Xu E; Al-Aly Z
    BMJ; 2022 Feb; 376():e068993. PubMed ID: 35172971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients.
    Abel KM; Carr MJ; Ashcroft DM; Chalder T; Chew-Graham CA; Hope H; Kapur N; McManus S; Steeg S; Webb RT; Pierce M
    JAMA Netw Open; 2021 Nov; 4(11):e2134803. PubMed ID: 34783824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults.
    Nishimi K; Neylan TC; Bertenthal D; Seal KH; O'Donovan A
    JAMA Netw Open; 2022 Apr; 5(4):e227287. PubMed ID: 35420660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.
    Singanayagam A; Hakki S; Dunning J; Madon KJ; Crone MA; Koycheva A; Derqui-Fernandez N; Barnett JL; Whitfield MG; Varro R; Charlett A; Kundu R; Fenn J; Cutajar J; Quinn V; Conibear E; Barclay W; Freemont PS; Taylor GP; Ahmad S; Zambon M; Ferguson NM; Lalvani A;
    Lancet Infect Dis; 2022 Feb; 22(2):183-195. PubMed ID: 34756186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic drug prescribing before and during the COVID-19 pandemic among people with depressive and anxiety disorders: a multinational network study.
    Luo H; Chai Y; Li S; Lau WCY; Torre CO; Hayes J; Lam ICH; Lin X; Yin C; Fortin S; Kern DM; Lee DY; Park RW; Jang JW; Chui CSL; Li J; Seager S; Man KKC; Wong ICK
    Lancet Psychiatry; 2024 Oct; 11(10):807-817. PubMed ID: 39241791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic.
    Valtuille Z; Acquaviva E; Trebossen V; Ouldali N; Bourmaud A; Sclison S; Gomez A; Revet A; Peyre H; Delorme R; Kaguelidou F
    JAMA Netw Open; 2024 Apr; 7(4):e247965. PubMed ID: 38652474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.
    Nemani K; Williams SZ; Olfson M; Leckman-Westin E; Finnerty M; Kammer J; Smith TE; Silverman DJ; Lindenmayer JP; Capichioni G; Clelland J; Goff DC
    JAMA Netw Open; 2022 May; 5(5):e2210743. PubMed ID: 35522282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and Risk for Mental Disorders Among Adults in Denmark.
    Nersesjan V; Christensen RHB; Kondziella D; Benros ME
    JAMA Psychiatry; 2023 Aug; 80(8):778-786. PubMed ID: 37223890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between COVID-19 vaccination and incident psychiatric disorders after breakthrough SARS-CoV-2 infection: The VENUS Study.
    Murata F; Maeda M; Murayama K; Nakao T; Fukuda H
    Brain Behav Immun; 2024 Mar; 117():521-528. PubMed ID: 38355026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
    Javelot H; Llorca PM; Drapier D; Fakra E; Hingray C; Meyer G; Dizet S; Egron A; Straczek C; Roser M; Masson M; Gaillard R; Fossati P; Haffen E
    Encephale; 2020 Jun; 46(3S):S14-S34. PubMed ID: 32376004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
    Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
    Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
    Taquet M; Geddes JR; Husain M; Luciano S; Harrison PJ
    Lancet Psychiatry; 2021 May; 8(5):416-427. PubMed ID: 33836148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
    Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
    Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults.
    Bliddal M; Rasmussen L; Andersen JH; Jensen PB; Pottegård A; Munk-Olsen T; Kildegaard H; Wesselhoeft R
    JAMA Psychiatry; 2023 Feb; 80(2):176-180. PubMed ID: 36515919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of post-COVID psychiatric disorders according to the periods of SARS-CoV-2 variant dominance: The LIFE study.
    Murata F; Maeda M; Murayama K; Nakao T; Fukuda H
    J Psychiatr Res; 2024 Jun; 174():12-18. PubMed ID: 38598975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.